MetLife Inc. (MET) closed its shares at USD 95.92 on the NYSE on September 22, 2026, marking a slight decline of 0.75 percent from the prior session. The stock price hovered near the USD 96 level as investors digested mixed signals from the company's second-quarter financial results and recent analyst sentiment. Financially, MetLife reported adjusted earnings per share (EPS) of USD 2.43 for the second quarter of 2026, which exceeded the consensus FactSet estimate of USD 2.30. However, total revenue came in at USD 13.65 billion, falling significantly short of the FactSet forecast of USD 19.67 billion, creating a divergence between profitability and top-line growth expectations. Analyst sentiment has shifted positively following an upgrade to a Buy rating by Kabutan on September 22, 2026. The broader analyst consensus currently projects an average price target of USD 105.75, representing a potential upside of approximately 10.25 percent from the closing price, with individual targets ranging between USD 84.00 and USD 119.00. The market is currently weighing the strength of MetLife's adjusted earnings beat against its underwhelming revenue performance. While the stock remains close to the USD 96 mark, the upgraded rating suggests that analysts view the company's profitability metrics as a more reliable indicator of value than the reported revenue shortfall at this time.